SC
TNDM icon

Stephens Consulting’s Tandem Diabetes Care TNDM Stock Holding History

Stephens Consulting’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20
Closed -$384 – 1939
2025
Q1 		$384 Buy
+20
New +$585 ﹤0.01% 1115

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Stephens Consulting's TNDM Position: Q2 2025 in Review

Stephens Consulting sold out of Tandem Diabetes Care (TNDM) in Q2 2025, closing a stake of 20 shares — an estimated $384 sold.

Stephens Consulting first reported a position in TNDM in Q1 2025 and held it in 1 quarter. The position peaked at $384 in Q1 2025. 270 funds tracked by Wall St. Rank hold TNDM as of Q2 2025.

  • Stephens Consulting reported no remaining Tandem Diabetes Care position as of Q2 2025 after selling out during the quarter.
  • Stephens Consulting sold 20 Tandem Diabetes Care shares in Q2 2025, an estimated $384.
  • Stephens Consulting first reported a position in Tandem Diabetes Care in Q1 2025 and held it in 1 quarter.
  • Stephens Consulting's Tandem Diabetes Care position peaked at $384 in Q1 2025.
  • 270 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2025.

Based on Stephens Consulting's 13F filing for Q2 2025, filed 25 Jul 2025.